Exelixis
EXEL
#2109
Rank
โ‚ฌ6.80 B
Marketcap
23,84ย โ‚ฌ
Share price
-1.53%
Change (1 day)
18.18%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚ฌ6.80 Billion

As of September 2024 Exelixis has a market cap of โ‚ฌ6.80 Billion. This makes Exelixis the world's 2109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024โ‚ฌ6.80 B0.77%
2023โ‚ฌ6.74 B39.91%
2022โ‚ฌ4.82 B-5.12%
2021โ‚ฌ5.08 B-0.2%
2020โ‚ฌ5.09 B6.83%
2019โ‚ฌ4.76 B-7.4%
2018โ‚ฌ5.14 B-31.31%
2017โ‚ฌ7.49 B82.4%
2016โ‚ฌ4.10 B248.96%
2015โ‚ฌ1.17 B408.21%
2014โ‚ฌ0.23 B-71.7%
2013โ‚ฌ0.81 B28.91%
2012โ‚ฌ0.63 B28.5%
2011โ‚ฌ0.49 B-26.91%
2010โ‚ฌ0.67 B21.73%
2009โ‚ฌ0.55 B47.86%
2008โ‚ฌ0.37 B-38.72%
2007โ‚ฌ0.61 B-6.35%
2006โ‚ฌ0.65 B-1.28%
2005โ‚ฌ0.66 B40.75%
2004โ‚ฌ0.47 B17.11%
2003โ‚ฌ0.40 B-11.46%
2002โ‚ฌ0.45 B-56.99%
2001โ‚ฌ1.05 B45.65%
2000โ‚ฌ0.72 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Exelixis was reported to be:

โ‚ฌ6.80 Billion
by Yahoo Finance info icon info icon
โ‚ฌ6.80 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ6.80 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
โ‚ฌ76.20 B 1,020.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ130.37 B 1,816.99%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ268.01 B 3,840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ90.39 B 1,229.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ163.59 B 2,305.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ356.60 B 5,143.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ150.44 B 2,112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ31.88 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.47 B-93.08%๐Ÿ‡บ๐Ÿ‡ธ USA